Natera's 'Signatera' detects recurrence of cancer through a blood test

Name: Natera's 'Signatera' detects recurrence of cancer through a blood test
Uploaded: 2025-07-09T01:24:47Z
Duration: 8 min 47 s
Description: Natera CEO Steve Chapman discusses the evolution of the company over ten years and how the company helps cancer patients on 'The Claman Countdown.'

FBN · Jul 9, 2025 · 8m 47s

Sign Up Now

Already a subscriber?

Natera CEO Steve Chapman discusses the evolution of the company over ten years and how the company helps cancer patients on 'The Claman Countdown.'